|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
BNC|981060915835306706
(VIAF cluster)
|
|
005
|
|
|
20230309133434.0 |
|
008
|
|
|
230201 ||azznnaabn |a aaa |
|
003
|
|
|
BNC |
|
035
|
|
|
‡a
(BNC)981060915835306706
|
|
024
|
7 |
|
‡a
87382295
‡2
viaf
‡1
http://viaf.org/viaf/87382295
|
|
040
|
|
|
‡a
ES-BaBC
‡b
cat
‡e
rda
‡c
ES-BaBC
|
|
100
|
1 |
|
‡a
Lázaro Quintela, M.
|
|
400
|
1 |
|
‡a
Lázaro Quintela, Martín
|
|
400
|
1 |
|
‡a
Lázaro, Martín
|
|
670
|
|
|
‡a
Autoridades BNE, consulta feta l'1 de febrer, 2023
‡b
(punt d'accés: Lázaro Quintela, M.)
|
|
901
|
|
|
‡a
978849475534
‡9
1
|
|
909
|
|
|
‡a
(viaf) 87382295
‡9
1
|
|
910
|
|
|
‡a
renalink
‡A
Renalink
‡l
spa
‡9
1
|
|
910
|
|
|
‡a
elmanejodelpacientecomplejoconcarcinomadecelulasrenales
‡A
En el manejo del paciente complejo con carcinoma de células renales.
‡l
spa
‡9
1
|
|
910
|
|
|
‡a
casosclinicosenelmanejodelpacientecomplejoconcarcinomadecelulasrenales
‡A
Casos clínicos en el manejo del paciente complejo con carcinoma de células renales.
‡l
spa
‡9
1
|
|
920
|
|
|
‡a
978-8494
‡9
1
|
|
921
|
|
|
‡a
kr medicine s l
‡b
KR Medicine, S.L.,
‡9
1
|
|
922
|
|
|
‡a
‡z
spc
‡9
1
|
|
940
|
|
|
‡a
spa
‡9
1
|
|
944
|
|
|
‡a
am
‡9
1
|
|
996
|
|
|
‡2
LC|nr 90028423
|
|
996
|
|
|
‡2
WKP|Q93020154
|
|
996
|
|
|
‡2
WKP|Q41150863
|
|
996
|
|
|
‡2
WKP|Q58165795
|
|
996
|
|
|
‡2
WKP|Q101562176
|
|
996
|
|
|
‡2
RERO|A003185828
|
|
996
|
|
|
‡2
BNF|13617551
|
|
996
|
|
|
‡2
SUDOC|056584784
|
|
996
|
|
|
‡2
ISNI|0000000066548854
|
|
996
|
|
|
‡2
WKP|Q83993014
|
|
996
|
|
|
‡2
DNB|1157273424
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Lázaro Quintela, M.
‡2
BNE|XX1644310
‡3
viafid
‡3
standard number
|
|
999
|
|
|
‡2
BNCBIB|991060915836306706
|
